BMJ 2000;320:1635-1640 ( 17 June )

Papers

US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey

Lisa M Schwartz, assistant professor of medicinea Steven Woloshin, assistant professor of medicinea Harold C Sox, Joseph M Huber professorb Baruch Fischhoff, professorc H Gilbert Welch, associate professor of medicinea

a Veterans Administration Outcomes Group (111B), Veterans Administration Medical Center, White River Junction, VT 05009, USA, b Department of Medicine, Dartmouth-Hitchock Medical Center, Lebanon, NH 03756, USA, c Department of Social and Decision Sciences, Carnegie Mellon University, Pittsburgh, PA 15213, USA

Correspondence to: L M Schwartz lisa.schwartz{at}dartmouth.edu

Objective: To determine women's attitudes to and knowledge of both false positive mammography results and the detection of ductal carcinoma in situ after screening mammography.
Design: Cross sectional survey.
Setting: United States.
Participants: 479 women aged 18-97 years who did not report a history of breast cancer.
Main outcome measures: Attitudes to and knowledge of false positive results and the detection of ductal carcinoma in situ after screening mammography.
Results: Women were aware that false positive results do occur. Their median estimate of the false positive rate for 10 years of annual screening was 20% (25th percentile estimate, 10%; 75th percentile estimate, 45%). The women were highly tolerant of false positives: 63% thought that 500 or more false positives per life saved was reasonable and 37% would tolerate 10 000 or more. Women who had had a false positive result (n=76) expressed the same high tolerance: 39% would tolerate 10 000 or more false positives. 62% of women did not want to take false positive results into account when deciding about screening. Only 8% of women thought that mammography could harm a woman without breast cancer, and 94% doubted the possibility of non-progressive breast cancers. Few had heard about ductal carcinoma in situ, a cancer that may not progress, but when informed, 60% of women wanted to take into account the possibility of it being detected when deciding about screening.
Conclusions: Women are aware of false positives and seem to view them as an acceptable consequence of screening mammography. In contrast, most women are unaware that screening can detect cancers that may never progress but feel that such information would be relevant. Education should perhaps focus less on false positives and more on the less familiar outcome of detection of ductal carcinoma in situ.



© BMJ 2000

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Participation in mammography screening
Lisa M Schwartz and Steven Woloshin
BMJ 2007 335: 731-732. [Extract] [Full Text] [PDF]

Content of invitations for publicly funded screening mammography
Karsten Juhl Jørgensen and Peter C Gøtzsche
BMJ 2006 332: 538-541. [Full Text] [PDF]

Model of outcomes of screening mammography: Authors' reply
Alexandra Barratt, Kirsten Howard, Les Irwig, Glenn Salkeld, and Nehmat Houssami
BMJ 2005 331: 351. [Extract] [Full Text]

Women's attitudes to false positive mammography results
Carol Jean Godby, Anne Peticolas, Joyce M Carter, Samuel Ghebrehewet, Steven Woloshin, Lisa Schwartz, H Gilbert Welch, and Harold C Sox
BMJ 2000 321: 1409. [Extract] [Full Text]

A week of overexcitement
BMJ 2000 320: 0. [Full Text] [PDF]

A week of overexcitement
BMJ 2000 320: 0. [Full Text] [PDF]

Women are unaware that mammography may detect non-progressive cancer
BMJ 2000 320: 0. [Full Text]

This article has been cited by other articles:

  • Schwartz, L. M, Woloshin, S. (2007). Participation in mammography screening. BMJ 335: 731-732 [Full text]  
  • Brewer, N. T., Salz, T., Lillie, S. E. (2007). Systematic Review: The Long-Term Effects of False-Positive Mammograms. ANN INTERN MED 146: 502-510 [Abstract] [Full text]  
  • Qaseem, A., Snow, V., Sherif, K., Aronson, M., Weiss, K. B., Owens, D. K., for the Clinical Efficacy Assessment Subcommittee, (2007). Screening Mammography for Women 40 to 49 Years of Age: A Clinical Practice Guideline from the American College of Physicians. ANN INTERN MED 146: 511-515 [Abstract] [Full text]  
  • Keen, J. D., Keen, J. E., Ganott, M. A., Sumkin, J. H., Gur, D. (2007). Does the Marginal Benefit Exceed the Marginal Cost?. Radiology 243: 299-300 [Full text]  
  • Gostin, L. O. (2007). HIV Screening and False-Positive Results--Reply. JAMA 297: 948-948 [Full text]  
  • Black, W. C. (2006). Randomized Clinical Trials for Cancer Screening: Rationale and Design Considerations for Imaging Tests. JCO 24: 3252-3260 [Abstract] [Full text]  
  • Jorgensen, K. J., Gotzsche, P. C (2006). Content of invitations for publicly funded screening mammography.. BMJ 332: 538-541 [Full text]  
  • Ganott, M. A., Sumkin, J. H., King, J. L., Klym, A. H., Catullo, V. J., Cohen, C. S., Gur, D. (2006). Screening Mammography: Do Women Prefer a Higher Recall Rate Given the Possibility of Earlier Detection of Cancer?. Radiology 238: 793-800 [Abstract] [Full text]  
  • Barratt, A., Howard, K., Irwig, L., Salkeld, G., Houssami, N. (2005). Model of outcomes of screening mammography: Authors' reply. BMJ 331: 351-351 [Full text]  
  • Nekhlyudov, L., Li, R., Fletcher, S. W. (2005). Information and Involvement Preferences of Women in Their 40s Before Their First Screening Mammogram. Arch Intern Med 165: 1370-1374 [Abstract] [Full text]  
  • Jorgensen, K. J., Gotzsche, P. C (2004). Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. BMJ 328: 148- [Abstract] [Full text]  
  • Smith, R. A., Saslow, D., Andrews Sawyer, K., Burke, W., Costanza, M. E., Evans, W. P. III, Foster, R. S. Jr., Hendrick, E., Eyre, H. J., Sener, S. (2003). American Cancer Society Guidelines for Breast Cancer Screening: Update 2003. CA Cancer J Clin 53: 141-169 [Abstract] [Full text]  
  • Black, W. C., Brant-Zawadzki, M. N. (2002). Invited Commentary * Author's Response. RadioGraphics 22: 1536-1539 [Full text]  
  • Ernster, V. L., Ballard-Barbash, R., Barlow, W. E., Zheng, Y., Weaver, D. L., Cutter, G., Yankaskas, B. C., Rosenberg, R., Carney, P. A., Kerlikowske, K., Taplin, S. H., Urban, N., Geller, B. M. (2002). Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography. JNCI J Natl Cancer Inst 94: 1546-1554 [Abstract] [Full text]  
  • Humphrey, L. L., Helfand, M., Chan, B. K.S., Woolf, S. H. (2002). Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED 137: 347-360 [Abstract] [Full text]  
  • Sox, H. (2002). Screening Mammography for Younger Women: Back to Basics. ANN INTERN MED 137: 361-362 [Full text]  
  • Hall, F. M., Patz, E. F. Jr, Black, W. C., Goodman, P. C. (2002). Screening for Lung Cancer: Been There and Done That * Dr Patz and colleagues respond:. Radiology 224: 928-929 [Full text]  
  • Schwartz, L. M., Woloshin, S. (2002). News Media Coverage of Screening Mammography for Women in Their 40s and Tamoxifen for Primary Prevention of Breast Cancer. JAMA 287: 3136-3142 [Abstract] [Full text]  
  • Chamot, E, Perneger, T V (2001). Misconceptions about efficacy of mammography screening: a public health dilemma. J. Epidemiol. Community Health 55: 799-803 [Abstract] [Full text]  
  • Foucar, E. (2001). Predictive genetics and predictive morphology have certain similarities. BMJ 323: 514-514 [Full text]  
  • Welch, H. G. (2001). Informed Choice in Cancer Screening. JAMA 285: 2776-2778 [Full text]  
  • Miller, A. B, Rozenberg, S., Carly, B., Liebens, F., Ham, H., Baum, M., Tobias, J S (2000). Effect of screening programme on mortality from breast cancer. BMJ 321: 1527a-1527 [Full text]  
  • Godby, C. J., Peticolas, A., Carter, J. M, Ghebrehewet, S., Woloshin, S., Schwartz, L., Welch, H G., Sox, H. C (2000). Women's attitudes to false positive mammography results. BMJ 321: 1409-1409 [Full text]  
  • Black, W. C. (2000). Overdiagnosis: An Underrecognized Cause of Confusion and Harm in Cancer Screening. JNCI J Natl Cancer Inst 92: 1280-1282 [Full text]  
  • (2000). Women Know About -- and Accept -- False-Positive Mammograms. JWatch Women's Health 2000: 16-16 [Full text]  
  • (2000). Women Know About -- and Accept -- False-Positive Mammograms. JWatch General 2000: 7-7 [Full text]  

Rapid Responses:

Read all Rapid Responses

A formerly clueless patient responds
Carol Jean Godby
bmj.com, 17 Jun 2000 [Full text]
Unrealistic beliefs about screening benefits not really ruled out
Anne Peticolas
bmj.com, 19 Jun 2000 [Full text]
Survey on False Positives Belies Present Data and Obstacles to Health
C J Thompson
bmj.com, 23 Jun 2000 [Full text]
Sampling: a query?
Julie Christie
bmj.com, 6 Jul 2000 [Full text]
False conclusions about false positives?
Joyce M Carter, et al.
bmj.com, 12 Jul 2000 [Full text]
Mammography: what do women want, and what do they get?
Elliott Foucar
bmj.com, 17 Jul 2000 [Full text]
Ignorance about ductal carcinoma in situ
Eileen Barrett
bmj.com, 4 Aug 2000 [Full text]



Student BMJ

Sepsis

The latest guidlines will affect how we practice medicine

www.student.bmj.com

Listen to the latest BMJ Interview